©The Author(s) 2025.
World J Gastroenterol. Oct 21, 2025; 31(39): 111353
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111353
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111353
Table 2 Artificial intelligence-enabled digital pathology for histological assessment in inflammatory bowel diseases
| Ref. | Disease/number of patients | Type of study | Number of training samples | Number of test samples | AI/model | Main findings |
| Vande Casteele et al[66] | UC/88 patients | Retrospective, single center | 20 tissue regions | 88 biopsies | DL | Performance in identifying eosinophil counts: WSI (sensitivity = 86.4%, accuracy = 91.8%, F1 score = 0.89); Strong agreement with four human experts (ICC: 0.805-0.917) |
| Gui et al[69] | UC/307 patients | Prospective, multicenter | 97 biopsies | 41 biopsies | CAD-CNN | Discrimination between HR (PHRI < 1) and non-remission (PHRI ≥ 1) based on the presence of neutrophils (sensitivity = 78.0%, specificity = 91.7%, accuracy = 86.0%, ICC = 0.840) |
| Ohara et al[71] | UC/114 patients | Retrospective, single center | 2300 WSIs | 114 biopsies | DL | Rate of relapse higher for GCR ≤ 12% compared to GCR > 12% (45.0% vs 6.5%, P < 0.010) |
| Najdawi et al[68] | UC/577 patients | Retrospective, single center | 512 WSIs | 308 WSIs | CNN-RFC | HR prediction (NHI ≤ 1, accuracy = 97.0%) was comparable to expert pathologist assessments (κ = 0.910, Spearman’s correlation ρ = 0.890, P < 0.010) |
| Iacucci et al[70] | UC/273 patients | Prospective, multicenter | 118 biopsies | 375 biopsies (1); 154 biopsies (2) | CAD-CNN | (1) Performance in distinguishing HR from active inflammation: RHI (AUC = 0.850, accuracy = 80.0%, sensitivity = 94.0%, specificity = 76.0%); NHI (AUC = 0.860, accuracy = 81.0%, sensitivity = 89.0%, specificity = 79.0%); PHRI (AUC = 0.870, accuracy = 87.0%, sensitivity = 89.0%, specificity = 85.0%); and (2) The hazard ratio for disease recurrence according to PHRI was higher for AI assessment compared with pathologist evaluation (4.64 vs 3.56, P < 0.001) |
| Peyrin-Biroulet et al[73] | UC/NR | Retrospective, single center | 160 WSIs | 40 WSIs | CNN | The average ICC between histopathologists and the AI tool for histological assessment based on NHI (ICC = 0.872) |
| Ohara et al[72] | UC/96 patients | Prospective, single center | 11260 patches | 135 WSIs | DL | Histological evaluation based on neutrophil quantification in WSI (accuracy = 77.0%, F1 score = 79.0%). Prediction of histological scores (PHRI, NHI) by AI showed strong correlation with pathological diagnoses (Spearman’s ρ = 0.680-0.800, P < 0.050) |
| Klein et al[78] | CD/105 patients | Retrospective, single center | Biopsies NR | Biopsies NR | NNET | Differentiation of clinical phenotypes (sensitivity = 78.0%, specificity = 77.0%). Prediction of surgical intervention (sensitivity = 80.0%, specificity = 91.0%) |
| Kiyokawa et al[76] | CD/68 patients | Retrospective, single center | 619464 tile images | 308705 tile images | CNN | Adipocyte shrinkage and increased mast cell infiltration in sub-serosal adipose tissue anticipate postoperative recurrence (AUC = 0.995, accuracy = 96.9%, precision = 96.4%, sensitivity = 96.5%) |
| Wang et al[77] | CD/205 patients | Retrospective, multicenter | 310 WSIs | 278 WSIs | DL-CNN | Severity of myenteric plexitis (accuracy = 83.3%) and postoperative recurrence prediction (AUC = 0.980) |
| Rymarczyk et al[79] | UC/887 patients; CD/302 patients | Retrospective, multicenter | 2696 biopsies | 800 biopsies | RNN, FV + RF, SA-AbMILP | SA-AbMILP for automated histological assessment of: GS: Accuracy: 65.0%-85.0% (κ = 0.440-0.680); GHAS: Colon accuracy: 80.0%-89.0% (κ = 0.540-0.650); Ileum accuracy 65.0%-82.0% (κ = 0.460-0.670) |
| Furlanello et al[74] | IBD/52 patients | Prospective, single center | 4981 WSIs | 356 biopsies | DL | Automated quantification of basal plasmacytosis discriminates IBD from non-IBD (accuracy = 90.0%) |
- Citation: Minea H, Singeap AM, Minea M, Chiriac S, Stanciu C, Trifan A. Artificial intelligence in inflammatory bowel disease: Current applications and future directions. World J Gastroenterol 2025; 31(39): 111353
- URL: https://www.wjgnet.com/1007-9327/full/v31/i39/111353.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i39.111353